NO160370C - Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser. - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.

Info

Publication number
NO160370C
NO160370C NO802836A NO802836A NO160370C NO 160370 C NO160370 C NO 160370C NO 802836 A NO802836 A NO 802836A NO 802836 A NO802836 A NO 802836A NO 160370 C NO160370 C NO 160370C
Authority
NO
Norway
Prior art keywords
dioxyd
penam
compounds
preparation
physiologically active
Prior art date
Application number
NO802836A
Other languages
English (en)
Other versions
NO802836L (no
NO160370B (no
Inventor
Wayne Ernest Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO802836L publication Critical patent/NO802836L/no
Priority to NO83831082A priority Critical patent/NO160299C/no
Publication of NO160370B publication Critical patent/NO160370B/no
Publication of NO160370C publication Critical patent/NO160370C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/28—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with modified 2-carboxyl group
    • C07D499/32—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO802836A 1979-09-26 1980-09-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser. NO160370C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO83831082A NO160299C (no) 1979-09-26 1983-03-25 Nye penamforbindelser som kan anvendes som mellomprodukt for fremstilling av beta-laktamase-hemmende forbindelser.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/079,127 US4256733A (en) 1979-09-26 1979-09-26 Acetoxymethyl penam compounds as β-lactamase inhibitors

Publications (3)

Publication Number Publication Date
NO802836L NO802836L (no) 1981-03-27
NO160370B NO160370B (no) 1989-01-02
NO160370C true NO160370C (no) 1989-04-12

Family

ID=22148609

Family Applications (2)

Application Number Title Priority Date Filing Date
NO802836A NO160370C (no) 1979-09-26 1980-09-25 Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO83831082A NO160299C (no) 1979-09-26 1983-03-25 Nye penamforbindelser som kan anvendes som mellomprodukt for fremstilling av beta-laktamase-hemmende forbindelser.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO83831082A NO160299C (no) 1979-09-26 1983-03-25 Nye penamforbindelser som kan anvendes som mellomprodukt for fremstilling av beta-laktamase-hemmende forbindelser.

Country Status (36)

Country Link
US (1) US4256733A (no)
JP (1) JPS6016958B2 (no)
KR (1) KR840000796B1 (no)
AR (1) AR224547A1 (no)
AT (1) AT366384B (no)
AU (1) AU517074B2 (no)
BE (1) BE885389A (no)
CA (1) CA1150242A (no)
CH (1) CH645646A5 (no)
CS (1) CS212284B2 (no)
DD (1) DD153123A5 (no)
DE (1) DE3035995C2 (no)
DK (1) DK404980A (no)
EG (1) EG14888A (no)
ES (1) ES8106528A1 (no)
FI (2) FI67552C (no)
FR (1) FR2465736A1 (no)
GB (2) GB2059420B (no)
GR (1) GR70065B (no)
HU (1) HU183212B (no)
IE (2) IE50507B1 (no)
IL (1) IL61117A (no)
IN (1) IN154557B (no)
IT (1) IT1132754B (no)
LU (1) LU82795A1 (no)
MX (1) MX6580E (no)
NL (1) NL185923C (no)
NO (2) NO160370C (no)
NZ (1) NZ195058A (no)
PH (1) PH15697A (no)
PL (1) PL126949B1 (no)
PT (1) PT71837B (no)
SE (2) SE449865B (no)
SU (1) SU959628A3 (no)
YU (1) YU41733B (no)
ZA (1) ZA805132B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364957A (en) * 1979-09-26 1982-12-21 Pfizer Inc. Bis-esters of alkanediols as antibacterial agents
US4511512A (en) * 1980-05-01 1985-04-16 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Produktionsaktiensel skab) Substantially pure dicyclohexyl ammonium 6-β-bromo-penicillanate
US4361513A (en) * 1980-12-11 1982-11-30 Pfizer Inc. Esters of penicillanic acid sulfone
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4558042A (en) * 1981-05-06 1985-12-10 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
ZA826687B (en) * 1981-09-14 1983-07-27 Pfizer Beta-lactamase inhibiting 2-beta-substituted-2-alpha-methyl 5(r)penam-3-alpha-carboxylic acid 1,1-dioxides and intermediates therefor
JPS58185589A (ja) * 1982-04-23 1983-10-29 Taiho Yakuhin Kogyo Kk ペニシリン誘導体
JPS62198687A (ja) * 1986-02-27 1987-09-02 Taiho Yakuhin Kogyo Kk ２β−置換チオメチルペニシリン誘導体
US4861768A (en) * 1986-02-27 1989-08-29 Taiho Pharmaceutical Company, Limited 2 β-substituted thiomethylpenicillin derivatives and their preparation and use
SK63894A3 (en) * 1991-12-19 1995-03-08 Novo Nordisk As Method of preparation of beta-lactam antibiotic
CN115385934A (zh) * 2022-10-26 2022-11-25 北京纳百生物科技有限公司 一种舒巴坦半抗原及其合成方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN149747B (no) * 1977-06-07 1982-04-03 Pfizer

Also Published As

Publication number Publication date
GB2125037B (en) 1984-08-01
LU82795A1 (fr) 1981-04-17
NO160299C (no) 1989-04-05
NL185923C (nl) 1990-08-16
YU41733B (en) 1987-12-31
KR830003494A (ko) 1983-06-20
IE801095L (en) 1981-01-09
ZA805132B (en) 1981-12-30
SE8005714L (sv) 1981-03-27
IT8024920A0 (it) 1980-09-25
NL185923B (nl) 1990-03-16
ES495354A0 (es) 1981-08-16
FI67854B (fi) 1985-02-28
NO831082L (no) 1981-03-27
GB8319784D0 (en) 1983-08-24
IL61117A0 (en) 1980-11-30
AU6271380A (en) 1981-04-09
DE3035995C2 (de) 1985-01-10
PL226868A1 (no) 1981-10-16
IN154557B (no) 1984-11-10
AR224547A1 (es) 1981-12-15
GR70065B (no) 1982-07-26
FR2465736B1 (no) 1982-04-30
FR2465736A1 (fr) 1981-03-27
IT1132754B (it) 1986-07-02
IE50507B1 (en) 1986-04-30
CA1150242A (en) 1983-07-19
HU183212B (en) 1984-04-28
NL8005344A (nl) 1981-03-30
BE885389A (fr) 1981-03-25
CH645646A5 (fr) 1984-10-15
IE801998L (en) 1981-03-26
NZ195058A (en) 1982-12-07
PT71837A (en) 1980-10-01
GB2059420A (en) 1981-04-23
JPS6016958B2 (ja) 1985-04-30
DE3035995A1 (de) 1981-04-02
KR840000796B1 (ko) 1984-06-12
SE8500965D0 (sv) 1985-02-27
IL61117A (en) 1983-10-31
EG14888A (en) 1985-06-30
AT366384B (de) 1982-04-13
GB2125037A (en) 1984-02-29
AU517074B2 (en) 1981-07-09
NO802836L (no) 1981-03-27
FI67552C (fi) 1985-04-10
GB2059420B (en) 1984-03-14
PL126949B1 (en) 1983-09-30
SU959628A3 (ru) 1982-09-15
CS212284B2 (en) 1982-03-26
FI840367A0 (fi) 1984-01-30
US4256733A (en) 1981-03-17
IE50506B1 (en) 1986-04-30
YU244980A (en) 1983-02-28
ES8106528A1 (es) 1981-08-16
FI67552B (fi) 1984-12-31
NO160299B (no) 1988-12-27
FI803028A (fi) 1981-03-27
FI67854C (fi) 1985-06-10
SE449865B (sv) 1987-05-25
JPS5657788A (en) 1981-05-20
MX6580E (es) 1985-07-24
SE461528B (sv) 1990-02-26
NO160370B (no) 1989-01-02
PH15697A (en) 1983-03-14
FI840367A (fi) 1984-01-30
ATA474680A (de) 1981-08-15
DK404980A (da) 1981-03-27
PT71837B (en) 1981-07-09
DD153123A5 (de) 1981-12-23

Similar Documents

Publication Publication Date Title
NO145657C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkenderivater.
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO151362C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive urinstoffderivater.
NO803851L (no) Fremgangsmaate til fremstilling av 4,1`,6`-triklor-4,1`,6`-trideoksy-galaktosukrose
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO150203C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive 4-hydroksy-2h-1,2-benzotiazin-3-karboksamid-1,1-dioksyder
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO154058C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-heterocyklyl-4-piperidinaminer.
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO870240D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO150638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive, basiske ethere
NO802015L (no) Fremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO152649C (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive fenylalkylaminer.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO149428C (no) Fremgangsmaate for fremstilling av fysiologisk aktive prostaglandinderivater.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO148644C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive sukkerderivater.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO147483C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylpyrimidiner.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.